Holley Performance Brands Demonstrates Strong Momentum and Product Innovation at SEMA 2025

Holley Performance Brands Demonstrates Strong Momentum and Product Innovation at SEMA 2025 Portfolio of iconic brands continues to cement Holley's aftermarket leadership and deliver comprehensive performance solutions for enthusiasts worldwide GlobeNewswire October 30, 2025 BOWLING GREEN, Ky., Oct. 30, 2025 (GLOBE NEWSWIRE) — Holley Performance Brands (NYSE: HLLY), a leader in automotive aftermarket performance solutions, […]

Lexicon Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025

Lexicon Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025 GlobeNewswire October 30, 2025 THE WOODLANDS, Texas, Oct. 30, 2025 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will release its third quarter 2025 financial results on Thursday, November 6, 2025, prior to market open. Management will conduct

Lantheus Announces FDA Grants PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)

Lantheus Announces FDA Grants PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs) PDUFA Date Set for March 29, 2026 GlobeNewswire October 30, 2025 BEDFORD, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling

InterDigital Announces Financial Results For Third Quarter 2025

InterDigital Announces Financial Results For Third Quarter 2025 GlobeNewswire October 30, 2025 New license agreements drive Revenue and EPS above increased outlookAnnualized recurring revenue1 at all-time high of $588 million, up 49% YoY WILMINGTON, Del., Oct. 30, 2025 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq: IDCC), a mobile, video, and AI technology research and development company,

Capital Clean Energy Carriers Corp. Announces Third Quarter 2025 Financial Results

Capital Clean Energy Carriers Corp. Announces Third Quarter 2025 Financial Results GlobeNewswire October 30, 2025 ATHENS, Greece, Oct. 30, 2025 (GLOBE NEWSWIRE) — Capital Clean Energy Carriers Corp. (the “Company”, “CCEC”, “we” or “us”) (NASDAQ: CCEC), an international owner of ocean-going vessels, today released its financial results for the third quarter ended September 30, 2025.

ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting

ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting GlobeNewswire October 30, 2025 SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing

Intelligent Bio Solutions Secures 33 New Customer Accounts in the Fiscal 2026 First Quarter, Showing Strong Year-Over-Year Growth and Increasing Total Active Accounts to 480

Intelligent Bio Solutions Secures 33 New Customer Accounts in the Fiscal 2026 First Quarter, Showing Strong Year-Over-Year Growth and Increasing Total Active Accounts to 480 GlobeNewswire October 30, 2025 NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive

Aterian Sets Date for Third Quarter 2025 Earnings Announcement & Investor Conference Call

Aterian Sets Date for Third Quarter 2025 Earnings Announcement & Investor Conference Call GlobeNewswire October 30, 2025 SUMMIT, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) — Aterian, Inc. (Nasdaq: ATER), a consumer products company, today announced that it will issue its financial results for the third quarter ended September 30, 2025 on Thursday, November 13, 2025

Allogene Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update

Allogene Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update GlobeNewswire October 30, 2025 Conference Call and Webcast Scheduled for November 6, 2025 at 2:00 p.m. PT/5:00 p.m. ET SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of

Scroll to Top